Astellas Pharma Inc. is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea, Taiwan and other markets through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, atopic dermatitis and other diseases. The Company also engages in the research and development of ophthalmology pharmaceuticals through its subsidiaries.
|Yoshitsugu Shitaka||-||-||Executive Officer, President of Subsidiary|
|Takuya Oshida||-||2016||Executive Officer, Chief Director of Medical Affairs|
|Kazuhiro Sako||-||-||Executive Officer, President of Subsidiary|
|Fumiaki Sakurai||-||2018||Executive Officer|
|Taiji Sawamoto||-||2017||Executive Officer, Director of Research Program Promotion in Main Research Unit|
|Hideki Shima||-||2017||Executive Officer, Director of Technology Planning in Main Pharmaceutical Technology Unit|
|Yasuhiro Kanzaki||-||2016||Executive Officer, Manager of Osaka Office in Main Sales Unit|
|Yukio Matsui||-||2018||Executive Officer|
|Eisuke Nozawa||-||-||Executive Officer, Director of Pharmaceutical Affairs|
|Naoki Okamura||-||2018||Executive Officer|
|Tadashi Hara||-||2017||Executive Officer, Director of Sales Strategy in Main Sales Unit|
|Masaaki Hirano||-||-||Executive Officer, Director of Business Planning|
|Yoshihiko Hatanaka||62||2018||Chairman of the Board, Chairman of the Board of Directors, Representative Director|
|Mitsunori Matsuda||-||2017||Senior Executive Officer, Chief Director of Pharmaceutical Technology|
|Chikashi Takeda||-||2018||Senior Executive Officer|
|Masatoshi Kuroda||-||2017||Senior Executive Officer, Chief Director of Asia & Oceania Business|
|Atsushi Kamide||-||2018||Senior Executive Officer, Director of External Affairs|
|Akihiko Iwai||-||2018||Senior Executive Officer, Chief Director of Research|
|Nobuaki Tanaka||-||2018||Senior Executive Officer, Chief Director of Sales|
|Kenji Yasukawa||58||2018||President, Chief Executive Officer, Representative Director|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.